Systemic immune activation as a potential determinant of wasting in Zambians with HIV-related diarrhoea

被引:18
作者
Kelly, P
Summerbell, C
Ngwenya, B
Mandanda, B
Hosp, M
Fuchs, D
Wachter, H
Luo, NP
Pobee, JOM
Farthing, MJG
机构
[1] UNIV ZAMBIA, SCH MED, LUSAKA, ZAMBIA
[2] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, A-6020 INNSBRUCK, AUSTRIA
[3] UNIV INNSBRUCK, LUDWIG BOLTZMANN INST AIDS RES, A-6020 INNSBRUCK, AUSTRIA
基金
英国惠康基金;
关键词
D O I
10.1093/qjmed/89.11.831
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Wasting in African AIDS patients is severe, and its aetiology is probably multifactorial: persistent diarrhoea, poverty and tuberculosis may all contribute. We report a cross-sectional study of body composition measured anthropometrically in 75 adult patients with HIV-related persistent diarrhoea in Lusaka, and its relationship to gastrointestinal infection and systemic immune activation assessed using serum neopterin and soluble tumour necrosis factor receptor (sTNF-R55) concentrations. Patients as a group were generally severely wasted (mean body mass index (BMI) 15.8 kg/m(2), range 11-22), but the severity of wasting was related neither to oesophageal candidiasis nor to intestinal infection. In men but not women, all measures of nutritional status were negatively related to serum sTNF-R55 concentration (fat-free mass in men, r=-0.64; 95%Cl: -0.80, -0.41; p<0.0001). Some wasted patients had cutaneous features of malnutrition, again associated with higher sTNFR55 concentrations, and two had peripheral oedema. The diarrhoea-wasting syndrome in this part of Africa seems to be associated with evidence of high cytokine activity in men, rather than oesophageal candidiasis or any particular intestinal opportunistic infection. This immune activation requires further investigation in the context of the sex difference we have observed.
引用
收藏
页码:831 / 837
页数:7
相关论文
共 34 条
[1]   CLINICAL-FEATURES OF MICROSPORIDIOSIS IN PATIENTS WITH AIDS [J].
ASMUTH, DM ;
DEGIROLAMI, PC ;
FEDERMAN, M ;
EZRATTY, CR ;
PLESKOW, DK ;
DESAI, G ;
WANKE, CA .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (05) :819-825
[2]  
COLEBUNDERS RL, 1991, AIDS, V5, pS103
[3]   HIV-RELATED ENTEROPATHY IN ZAMBIA - A CLINICAL, MICROBIOLOGICAL, AND HISTOLOGICAL STUDY [J].
CONLON, CP ;
PINCHING, AJ ;
PERERA, CU ;
MOODY, A ;
LUO, NP ;
LUCAS, SB .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1990, 42 (01) :83-88
[4]  
*DHS, 1993, DEM HLTH SURV 1992
[5]   SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CLINICAL LABORATORY DIAGNOSIS [J].
DIEZRUIZ, A ;
TILZ, GP ;
ZANGERLE, R ;
BAIERBITTERLICH, G ;
WACHTER, H ;
FUCHS, D .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) :1-8
[6]   HUMAN MICROSPORIDIOSIS IN AFRICAN AIDS PATIENTS WITH CHRONIC DIARRHEA [J].
DROBNIEWSKI, F ;
KELLY, P ;
CAREW, A ;
NGWENYA, B ;
LUO, N ;
PANKHURST, C ;
FARTHING, M .
JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) :515-516
[7]  
DUMIN JVG, 1974, BR J NUTR, V32, P77
[8]   NEOPTERIN AS A MARKER FOR ACTIVATED CELL-MEDIATED-IMMUNITY - APPLICATION IN HIV INFECTION [J].
FUCHS, D ;
HAUSEN, A ;
REIBNEGGER, G ;
WERNER, ER ;
DIERICH, MP ;
WACHTER, H .
IMMUNOLOGY TODAY, 1988, 9 (05) :150-155
[9]  
GARROW JS, 1985, INT J OBESITY, V9, P147
[10]   THE CLINICAL CHALLENGE OF THE HIV EPIDEMIC IN THE DEVELOPING-WORLD [J].
GILKS, CF .
LANCET, 1993, 342 (8878) :1037-1039